Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FAREHA KAZI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1598797060
CMS profile
299740
Location
FRISCO, TX

General Payments · PY2019–2024

$1,639.61

  • Reported across 77 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$453.90

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $453.90 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $25.89 2
PY2020 $122.74 8
PY2021 $340.24 18
PY2022 $304.49 12
PY2023 $392.35 21
PY2024 $453.90 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $23.80 03/05/2024 Food and Beverage Undisputed 01/23/2026 1111616327 CMS
Amgen Inc. $20.71 04/16/2024 Food and Beverage Undisputed 01/23/2026 1111616329 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.57 12/17/2024 Food and Beverage Undisputed 01/23/2026 1118075407 CMS
CALLIDITAS THERAPEUTICS US INC. $17.28 12/03/2024 Food and Beverage Undisputed 01/23/2026 1141528421 CMS
Lundbeck LLC $19.76 03/05/2024 Food and Beverage Undisputed 01/23/2026 1145932239 CMS
Lundbeck LLC $20.44 05/01/2024 Food and Beverage Undisputed 01/23/2026 1145932241 CMS
Lundbeck LLC $18.55 06/04/2024 Food and Beverage Undisputed 01/23/2026 1145932243 CMS
Lundbeck LLC $18.53 09/10/2024 Food and Beverage Undisputed 01/23/2026 1145932245 CMS
Medtronic, Inc. $145.84 06/25/2024 Food and Beverage Undisputed 01/23/2026 1119394672 CMS
Neurocrine Biosciences, Inc. $21.47 05/21/2024 Food and Beverage Undisputed 01/23/2026 1150853185 CMS
Neurocrine Biosciences, Inc. $34.45 10/29/2024 Food and Beverage Undisputed 01/23/2026 1150819474 CMS
Novartis Pharmaceuticals Corporation $18.69 12/10/2024 Food and Beverage Undisputed 01/23/2026 1087114656 CMS
Novo Nordisk Inc $20.53 06/26/2024 Food and Beverage Undisputed 01/23/2026 1097083728 CMS
Otsuka America Pharmaceutical, Inc. $17.46 07/09/2024 Food and Beverage Undisputed 01/23/2026 1118919708 CMS
Otsuka America Pharmaceutical, Inc. $19.15 11/05/2024 Food and Beverage Undisputed 01/23/2026 1118919710 CMS
Sumitomo Pharma America, Inc. $16.67 01/12/2024 Food and Beverage Undisputed 01/23/2026 1148872709 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.